CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AbbVie Inc. v. Mylan Inc.

1:12-cv-00257

Overview

Case Number 1:12-cv-00257
Filing Date 2012-03-02
Status Terminated
Termination Date 2014-02-04
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Mylan Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

AbbVie Inc. Operating Company

Represented By

3 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Abbott Laboratories NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Plaintiff

AbbVie Respiratory LLC Operating Company

Represented By

3 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Abbott Respiratory LLC Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Mylan Inc. Operating Company

Represented By

6 Attorneys Listed

William A. Rakoczy

Email: wrakoczy@rmmslegal.com

Matthew V. Anderson

Email: manderson@rmmslegal.com

Eric R. Hunt

Email: ehunt@rmmslegal.com

Amy D. Brody

UNDELIVERABLE EMAIL 1/11/2022

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

9 Patents

There are 9 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6080428
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
Filed: 1995-01-14
Issued: 2000-06-27
Expired (Term Ended)
Expires: 2015-01-14
US6129930
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
Filed: 1997-03-06
Issued: 2000-10-10
Expired (Term Ended)
Expires: 2017-03-06
US6406715
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles
Filed: 1997-10-31
Issued: 2002-06-18
Expired (Term Ended)
Expires: 2017-10-31
US6469035
Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid
Filed: 1997-07-31
Issued: 2002-10-22
Expired (Term Ended) +227d PTA
Expires: 2018-03-15
US6676967
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
Filed: 1997-10-31
Issued: 2004-01-13
Expired (Term Ended)
Expires: 2017-10-31

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

5

Dispositive

0

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Procedural / Extension Motion 3 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Certain Deadlines to Proposed Dates Referenced in Stipulation - filed by AbbVie Inc., AbbVie Respiratory LLC, Mylan Inc., Mylan P...
Entry #28 • 2013-11-18 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME regarding expert discovery to various dates - filed by AbbVie Inc., AbbVie Respiratory LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (...
Entry #27 • 2013-10-15 Document →
Claim Construction / Markman Filing Pending
CLAIM Construction Chart by AbbVie Inc., AbbVie Respiratory LLC, Kremers Urban Pharmaceuticals Inc., Watson Laboratories Inc. - Florida, Mylan Inc., Mylan Pharm...
Entry #26 • 2013-08-15 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM Construction Chart by AbbVie Inc., AbbVie Respiratory LLC, Kremers Urban Pharmaceuticals Inc., Watson Laboratories Inc. - Florida, Mylan Inc., Mylan Pharm...
Entry #26 • 2013-08-15 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to the Complaint to through and including April 27, 2012 - filed by Mylan Inc., Mylan Pharmaceut...
Entry #5 • 2012-03-23 Document →

Docket Entries

(45 total)
Pleading / Complaint

COMPLAINT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1032801.) - filed by Abbott Respiratory LLC, Abbott Laboratories. (Attachments: # 1 Exhibit A-I, # 2 Civil Cover Sheet)(lih) (Entered: 03/05/2012)

Entry #1 • 2012-03-02
1
Pleading / Complaint

COMPLAINT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1032801.) - filed by Abbott Respiratory LLC, Abbott Laboratories. (Attachments: # 1 Exhibit A-I, # 2 Civil Cover Sheet)(lih) (Entered: 03/05/2012)

Entry #1 • 2012-03-02
2
Pleading / Complaint

COMPLAINT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1032801.) - filed by Abbott Respiratory LLC, Abbott Laboratories. (Attachments: # 1 Exhibit A-I, # 2 Civil Cover Sheet)(lih) (Entered: 03/05/2012)

Entry #1 • 2012-03-02
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (lih) (Entered: 03/05/2012)

Entry #2 • 2012-03-02
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/18/2012. Date of Expiration of Patent: '428 5/27/2017; '930 9/20/2013; '715 9/20/2012; '035 3/15/2018; '967 9/20/2013; '691 9/20/2012; '229 9/20/2013; '848 9/20/2013; '506 9/20/2013.Thirty Month Stay Deadline: 7/18/2014. (lih) (Entered: 03/05/2012)

Entry #3 • 2012-03-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc